Credit where it is due, PR and Co. have really structured things in a way to help turn things around in the most dramatic way possible. A brilliant way to top things off will be a partnership deal. Just imagine if PR announces a China deal in the next two weeks? Unlikely, but wouldn't it just top things off nicely?
MRI results in conjunction with all other results confirm DMOAD. I must admit that I only expected an improvement to BML at 6 months and no improvement in cartilage at 6 months since it just seemed too soon. iPPS basically now ticks all the boxes; pain and function, biomarkers, durability, mri etc. We can also expect a favourable outcome at the upcoming FDA meeting in Q1.
GLTAH
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-83
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33599 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 65498 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |